Sone-296 -
Key figures to include
| Model | Species | Dosing Regimen | Efficacy Readout | Key Result | |-------|--------|----------------|------------------|------------| | In‑vitro (e.g., tumor cell line panel) | – | 0.1‑10 µM | Viability (MTT) | IC₅₀ = 30 nM in XYZ line | | Xenograft (e.g., human A‑cell line in nude mice) | Mouse | 10 mg/kg PO daily | Tumor volume reduction | ‑78 % vs. control at Day 21 | | PDX (patient‑derived xenograft) | Mouse | 25 mg/kg PO QD | Survival extension | Median OS ↑ 3.2 months | | Safety‑toxicity (GLP repeat‑dose) | Rat / Dog | 0‑100 mg/kg | No‑observed‑adverse‑effect‑level (NOAEL) | ≥50 mg/kg | SONE-296
Interpretation
Sources
If you want, I can convert this into a ready-to-attach ticket template (with specific fields, estimated story points, and a checklist) or generate API schema examples and DB migration SQL for SONE-296. Which would you prefer? Key figures to include